Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease

AbstractObjective structed random forest classifiers employing either the traditional method of scoring semantic fluency word lists or new methods. These classifiers were then compared in terms of their ability to diagnose Alzheimer disease (AD) or to prognosticate among individuals along the continuum from cognitively normal (CN) through mild cognitive impairment (MCI) to AD. ic fluency lists from 44 cognitively normal elderly individuals, 80 MCI patients, and 41 AD patients were transcribed into electronic text files and scored by four methods: traditional raw scores, clustering and switching scores, “generalized” versions of clustering and switching, and a method based on independent components analysis (ICA). Random forest classifiers based on raw scores were compared to “augmented” classifiers that incorporated newer scoring methods. Outcome variables included AD diagnosis at baseline, MCI conversion, increase in Clinical Dementia Rating-Sum of Boxes (CDR-SOB) score, or decrease in Financial Capacity Instrument (FCI) score. Receiver operating characteristic (ROC) curves were constructed for each classifier and the area under the curve (AUC) was calculated. We compared AUC between raw and augmented classifiers using Delongʹs test and assessed validity and reliability of the augmented classifier. s ted classifiers outperformed classifiers based on raw scores for the outcome measures AD diagnosis (AUC .97 vs .95), MCI conversion (AUC .91 vs .77), CDR-SOB increase (AUC .90 vs .79), and FCI decrease (AUC .89 vs .72). Measures of validity and stability over time support the use of the method. sion information in semantic fluency word lists is useful for predicting cognitive and functional decline among elderly individuals at increased risk for developing AD. Modern machine learning methods may incorporate latent information to enhance the diagnostic value of semantic fluency raw scores. These methods could yield information valuable for patient care and clinical trial design with a relatively small investment of time and money.